FactaeThe Factual News

Top Stories Focus Media

Monde
France
Régional
Politique
Guerre
Défense & Sécurité

Économie
Marchés
Énergie
Crypto

Tech
Intelligence artificielle
Informatique
Cybersécurité

Science
Santé
Écologie

Histoire
Culture
Sport
Droit
Éducation

Factae

The Factual News

The intelligence of the news. Multi-source, geolocated, synthesized.

Live

Live feed Scoops Immersive map

Explore

Trading Board Trends AI models AI tools Sources

Information

About Methodology RSS feed Contact Terms Privacy Legal Newsletter

© 2026 Factae. All rights reserved.

CAC 40 wavers, biotech stocks diverge | Factae

CAC 40 wavers, biotech stocks diverge

The CAC 40 fluctuates slightly lower, weighed down by profit-taking after a volatile week.

Published 2sem·1 sourceMajor·updated 4j

Lire en français

≈ 14sSpeed

The fact

Biotech stocks show mixed performances, with rebounds and corrections.

Abivax and Genfit draw investor attention.

🔗Click the link to read an article on the topic:

🧭Explore this topic

Paris France CAC 40 Abivax Genfit #CAC 40 #biotech #marchés #Abivax #Genfit

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→

ParisWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on July 2, 2026

← Back to home

Discover

Read more

All marches →

Paris Stock Exchange plunges under biotech and Atos pressure

3sem · 1 source marches0.8 %

CAC 40 declines in session, Abivax suspended after regulatory announcement

2sem · 1 source marches

French biotech stocks volatile: GenFit, Innate Pharma, Abivax under pressure

12sem · 1 source sante

Biotech stocks show mixed moves in Paris

12sem · 1 source economie

French biotech companies divide investors on Paris market

12sem · 1 source marches

Discussion sur les pronostics boursiers d'Immuotherapeutics sur le forum Boursorama le 29/04/2026

11sem · 1 source